Predictive factors of progression to severe COVID-19

Early diagnosis and treatment are crucial for the survival of severe Coronavirus Disease 2019 (COVID-19) patients, but data with regard to risk factors for disease progression from milder COVID-19 to severe COVID-19 remain scarce. We conducted a retrospective analysis on 116 patients. Three factors...

Full description

Saved in:
Bibliographic Details
Published inOpen medicine (Warsaw, Poland) Vol. 15; no. 1; pp. 805 - 814
Main Authors Zhou, Yi-Hong, Li, Huan, Qin, Yuan-Yuan, Yan, Xiao-Feng, Lu, Yan-Qiu, Liu, Hong-Lan, Ye, Si-Kuan, Wan, Yan, Zhang, Lu, Harypursat, Vijay, Chen, Yaokai
Format Journal Article
LanguageEnglish
Published Poland De Gruyter 01.01.2020
Walter de Gruyter GmbH
Subjects
Coronavirus
Coronaviruses
COVID-19
Hospitalization
Hospitals
Infectious diseases
Laboratories
Medical diagnosis
Medical prognosis
Patients
predictive
progression
Public health
Risk factors
SARS-CoV-2
Sepsis
Severe acute respiratory syndrome coronavirus 2
COVID-19
predictive
progression
SARS-CoV-2
Coronavirus
Online AccessGet full text

Cover

Abstract Early diagnosis and treatment are crucial for the survival of severe Coronavirus Disease 2019 (COVID-19) patients, but data with regard to risk factors for disease progression from milder COVID-19 to severe COVID-19 remain scarce. We conducted a retrospective analysis on 116 patients. Three factors were observed to be independently associated with progression to severe COVID-19 during 14 days after admission: (a) age 65 years or older (hazard ratio [HR] = 8.456; 95% CI: 2.706-26.426); (b) creatine kinase (CK) ≥ 180 U/L (HR = 3.667; 95% CI: 1.253-10.733); and (c) CD4+ T-cell counts <300 cells/µL (HR = 4.695; 95% CI: 1.483-14.856). The difference in rates of severe COVID-19 development was found to be statistically significant between patients aged 65 years or older (46.2%) and those younger than 65 years (90.2%), between patients with CK ≥ 180 U/L (55.6%) and those with CK < 180 U/L (91.5%), and between patients with CD4+ T-cell counts <300 cells/µL (53.8%) and those with CD4+ cell counts ≥300 cells/µL (83.2%). Age ≥ 65 years, CK ≥ 180 U/L, and CD4+ T-cell counts <300 cells/µL at admission were risk factors independently associated with disease progression to severe COVID-19 during 14 days after admission and are therefore potential markers for disease progression in patients with milder COVID-19.
AbstractList Early diagnosis and treatment are crucial for the survival of severe Coronavirus Disease 2019 (COVID-19) patients, but data with regard to risk factors for disease progression from milder COVID-19 to severe COVID-19 remain scarce.Methods We conducted a retrospective analysis on 116 patients.Results Three factors were observed to be independently associated with progression to severe COVID-19 during 14 days after admission: (a) age 65 years or older (hazard ratio [HR] = 8.456; 95% CI: 2.706–26.426); (b) creatine kinase (CK) ≥ 180 U/L (HR = 3.667; 95% CI: 1.253–10.733); and (c) CD4+ T-cell counts <300 cells/µL (HR = 4.695; 95% CI: 1.483–14.856). The difference in rates of severe COVID-19 development was found to be statistically significant between patients aged 65 years or older (46.2%) and those younger than 65 years (90.2%), between patients with CK ≥ 180 U/L (55.6%) and those with CK < 180 U/L (91.5%), and between patients with CD4+ T-cell counts <300 cells/µL (53.8%) and those with CD4+ cell counts ≥300 cells/µL (83.2%).Conclusions Age ≥ 65 years, CK ≥ 180 U/L, and CD4+ T-cell counts <300 cells/µL at admission were risk factors independently associated with disease progression to severe COVID-19 during 14 days after admission and are therefore potential markers for disease progression in patients with milder COVID-19.
Early diagnosis and treatment are crucial for the survival of severe Coronavirus Disease 2019 (COVID-19) patients, but data with regard to risk factors for disease progression from milder COVID-19 to severe COVID-19 remain scarce.AIMEarly diagnosis and treatment are crucial for the survival of severe Coronavirus Disease 2019 (COVID-19) patients, but data with regard to risk factors for disease progression from milder COVID-19 to severe COVID-19 remain scarce.We conducted a retrospective analysis on 116 patients.METHODSWe conducted a retrospective analysis on 116 patients.Three factors were observed to be independently associated with progression to severe COVID-19 during 14 days after admission: (a) age 65 years or older (hazard ratio [HR] = 8.456; 95% CI: 2.706-26.426); (b) creatine kinase (CK) ≥ 180 U/L (HR = 3.667; 95% CI: 1.253-10.733); and (c) CD4+ T-cell counts <300 cells/µL (HR = 4.695; 95% CI: 1.483-14.856). The difference in rates of severe COVID-19 development was found to be statistically significant between patients aged 65 years or older (46.2%) and those younger than 65 years (90.2%), between patients with CK ≥ 180 U/L (55.6%) and those with CK < 180 U/L (91.5%), and between patients with CD4+ T-cell counts <300 cells/µL (53.8%) and those with CD4+ cell counts ≥300 cells/µL (83.2%).RESULTSThree factors were observed to be independently associated with progression to severe COVID-19 during 14 days after admission: (a) age 65 years or older (hazard ratio [HR] = 8.456; 95% CI: 2.706-26.426); (b) creatine kinase (CK) ≥ 180 U/L (HR = 3.667; 95% CI: 1.253-10.733); and (c) CD4+ T-cell counts <300 cells/µL (HR = 4.695; 95% CI: 1.483-14.856). The difference in rates of severe COVID-19 development was found to be statistically significant between patients aged 65 years or older (46.2%) and those younger than 65 years (90.2%), between patients with CK ≥ 180 U/L (55.6%) and those with CK < 180 U/L (91.5%), and between patients with CD4+ T-cell counts <300 cells/µL (53.8%) and those with CD4+ cell counts ≥300 cells/µL (83.2%).Age ≥ 65 years, CK ≥ 180 U/L, and CD4+ T-cell counts <300 cells/µL at admission were risk factors independently associated with disease progression to severe COVID-19 during 14 days after admission and are therefore potential markers for disease progression in patients with milder COVID-19.CONCLUSIONSAge ≥ 65 years, CK ≥ 180 U/L, and CD4+ T-cell counts <300 cells/µL at admission were risk factors independently associated with disease progression to severe COVID-19 during 14 days after admission and are therefore potential markers for disease progression in patients with milder COVID-19.
Early diagnosis and treatment are crucial for the survival of severe Coronavirus Disease 2019 (COVID-19) patients, but data with regard to risk factors for disease progression from milder COVID-19 to severe COVID-19 remain scarce.
Early diagnosis and treatment are crucial for the survival of severe Coronavirus Disease 2019 (COVID-19) patients, but data with regard to risk factors for disease progression from milder COVID-19 to severe COVID-19 remain scarce. We conducted a retrospective analysis on 116 patients. Three factors were observed to be independently associated with progression to severe COVID-19 during 14 days after admission: (a) age 65 years or older (hazard ratio [HR] = 8.456; 95% CI: 2.706-26.426); (b) creatine kinase (CK) ≥ 180 U/L (HR = 3.667; 95% CI: 1.253-10.733); and (c) CD4+ T-cell counts <300 cells/µL (HR = 4.695; 95% CI: 1.483-14.856). The difference in rates of severe COVID-19 development was found to be statistically significant between patients aged 65 years or older (46.2%) and those younger than 65 years (90.2%), between patients with CK ≥ 180 U/L (55.6%) and those with CK < 180 U/L (91.5%), and between patients with CD4+ T-cell counts <300 cells/µL (53.8%) and those with CD4+ cell counts ≥300 cells/µL (83.2%). Age ≥ 65 years, CK ≥ 180 U/L, and CD4+ T-cell counts <300 cells/µL at admission were risk factors independently associated with disease progression to severe COVID-19 during 14 days after admission and are therefore potential markers for disease progression in patients with milder COVID-19.
Author Zhang, Lu
Chen, Yaokai
Qin, Yuan-Yuan
Zhou, Yi-Hong
Li, Huan
Yan, Xiao-Feng
Ye, Si-Kuan
Lu, Yan-Qiu
Liu, Hong-Lan
Harypursat, Vijay
Wan, Yan
Author_xml – sequence: 1
  givenname: Yi-Hong
  surname: Zhou
  fullname: Zhou, Yi-Hong
  organization: Department of Infectious Diseases, Chongqing Public Health Medical Center, No. 109 Baoyu Road, Shapingba, Chongqing, 400036, China
– sequence: 2
  givenname: Huan
  surname: Li
  fullname: Li, Huan
  organization: Department of Infectious Diseases, Chongqing Public Health Medical Center, No. 109 Baoyu Road, Shapingba, Chongqing, 400036, China
– sequence: 3
  givenname: Yuan-Yuan
  surname: Qin
  fullname: Qin, Yuan-Yuan
  organization: Department of Infectious Diseases, Chongqing Public Health Medical Center, No. 109 Baoyu Road, Shapingba, Chongqing, 400036, China
– sequence: 4
  givenname: Xiao-Feng
  surname: Yan
  fullname: Yan, Xiao-Feng
  organization: Department of Infectious Diseases, Chongqing Public Health Medical Center, No. 109 Baoyu Road, Shapingba, Chongqing, 400036, China
– sequence: 5
  givenname: Yan-Qiu
  surname: Lu
  fullname: Lu, Yan-Qiu
  organization: Department of Infectious Diseases, Chongqing Public Health Medical Center, No. 109 Baoyu Road, Shapingba, Chongqing, 400036, China
– sequence: 6
  givenname: Hong-Lan
  surname: Liu
  fullname: Liu, Hong-Lan
  organization: Department of Tuberculosis, Chongqing Public Health Medical Center, Chongqing, China
– sequence: 7
  givenname: Si-Kuan
  surname: Ye
  fullname: Ye, Si-Kuan
  organization: Department of Tuberculosis, Chongqing Public Health Medical Center, Chongqing, China
– sequence: 8
  givenname: Yan
  surname: Wan
  fullname: Wan, Yan
  organization: Department of Infectious Diseases, Chongqing Public Health Medical Center, No. 109 Baoyu Road, Shapingba, Chongqing, 400036, China
– sequence: 9
  givenname: Lu
  surname: Zhang
  fullname: Zhang, Lu
  organization: Department of Infectious Diseases, Chongqing Public Health Medical Center, No. 109 Baoyu Road, Shapingba, Chongqing, 400036, China
– sequence: 10
  givenname: Vijay
  surname: Harypursat
  fullname: Harypursat, Vijay
  organization: Department of Infectious Diseases, Chongqing Public Health Medical Center, No. 109 Baoyu Road, Shapingba, Chongqing, 400036, China
– sequence: 11
  givenname: Yaokai
  surname: Chen
  fullname: Chen, Yaokai
  email: yaokaichen@hotmail.com
  organization: Department of Infectious Diseases, Chongqing Public Health Medical Center, No. 109 Baoyu Road, Shapingba, Chongqing, 400036, China
BackLink https://www.ncbi.nlm.nih.gov/pubmed/33336038$$D View this record in MEDLINE/PubMed
BookMark eNp1kc1v1DAQxS1URMvSI1cUiQuXwPgrjoWEhJavlSqVA3C1HGd28SobL7azqP89DltKW4Evtsa_9zQz7zE5GcOIhDyl8JJKKl_tsK8ZMKiBtuIBOWNc01qKhp_cep-S85S2AEAlV1rBI3LKy2mAt2dEfI7Ye5f9Aau1dTnEVIV1tY9hEzElH8YqhyrhASNWy8tvq3c11U_Iw7UdEp5f3wvy9cP7L8tP9cXlx9Xy7UXtJOe5tkJJTi062Qvao0DuqO20bVrUFkApCxQY69esaxjrnBMSJDrdib7lfbFYkNXRtw92a_bR72y8MsF687sQ4sbYmL0b0GjaoFMAXcu1aFvdqY5px5xthOQOZq83R6_91JW1ORxztMMd07s_o_9uNuFglKKMl0EW5MW1QQw_JkzZ7HxyOAx2xDAlw4Siomlowwr6_B66DVMcy6oKJYBxJvlMPbvd0U0rf8IpQH0EXAwpRVzfIBTMnL-ZZXP-Zs6_8Pwe73y2uWRYBvLDf1Wvj6qfdsgYe9zE6ao8_vb8T12ptCD5Lxplw-I
CitedBy_id crossref_primary_10_1002_14651858_CD015050_pub2
crossref_primary_10_3390_s21248503
crossref_primary_10_2217_epi_2023_0179
crossref_primary_10_3390_jcm12144638
Cites_doi 10.1002/jmv.25809
10.1017/S0950268818002923
10.1016/j.amjmed.2020.03.026
10.1093/cid/ciaa443
10.1002/dmrr.3319
10.1001/jama.2020.1585
10.1177/0885066615579858
10.1007/s00011-020-01342-0
10.1136/bmj.326.7403.1358
10.1001/archneur.62.7.1113
10.1056/NEJMoa030685
10.1016/S0140-6736(20)30154-9
10.1111/jgh.15047
10.1016/S1726-4901(09)70124-8
10.1056/NEJMoa2001316
10.1016/S1473-3099(13)70204-4
10.1186/s12879-017-2712-2
10.1016/S0140-6736(20)30185-9
10.1056/NEJMc2009787
10.1016/j.jinf.2020.03.004
10.1016/S0140-6736(20)30183-5
10.1016/j.tmaid.2019.03.004
10.1016/S0140-6736(20)30251-8
ContentType Journal Article
Copyright 2020 Yi-Hong Zhou et al., published by De Gruyter.
2020. This work is published under http://creativecommons.org/licenses/by/4.0 (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
2020 Yi-Hong Zhou ., published by De Gruyter 2020 Yi-Hong Zhou et al., published by De Gruyter
Copyright_xml – notice: 2020 Yi-Hong Zhou et al., published by De Gruyter.
– notice: 2020. This work is published under http://creativecommons.org/licenses/by/4.0 (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: 2020 Yi-Hong Zhou ., published by De Gruyter 2020 Yi-Hong Zhou et al., published by De Gruyter
DBID AAYXX
CITATION
NPM
3V.
7X7
7XB
8AO
8FI
8FJ
8FK
ABUWG
AFKRA
BENPR
CCPQU
FYUFA
GHDGH
K9.
M0S
PQEST
PQQKQ
PQUKI
7X8
5PM
DOA
DOI 10.1515/med-2020-0184
DatabaseName CrossRef
PubMed
ProQuest Central (Corporate)
ProQuest Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
ProQuest Pharma Collection
ProQuest Hospital Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central
ProQuest One Community College
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Health & Medical Complete (Alumni)
ProQuest Health & Medical Collection
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
PubMed
ProQuest One Academic Eastern Edition
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Pharma Collection
ProQuest Hospital Collection (Alumni)
ProQuest Central
ProQuest Health & Medical Complete
Health Research Premium Collection
ProQuest One Academic UKI Edition
Health and Medicine Complete (Alumni Edition)
ProQuest One Academic
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList ProQuest One Academic Eastern Edition
MEDLINE - Academic

PubMed
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: 7X7
  name: Health & Medical Collection
  url: https://search.proquest.com/healthcomplete
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Public Health
EISSN 2391-5463
EndPage 814
ExternalDocumentID oai_doaj_org_article_916ec700b8394889b7b29c2ca6453c03
PMC7712375
33336038
10_1515_med_2020_0184
10_1515_med_2020_0184151805
Genre Journal Article
GroupedDBID 53G
5VS
7X7
8AO
8FI
8FJ
AAFWJ
ABFKT
ABUWG
ACGFS
ADBBV
AENEX
AFBDD
AFKRA
AFPKN
AHGSO
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BCNDV
BENPR
BPHCQ
BVXVI
CCPQU
DIK
EBS
FYUFA
GROUPED_DOAJ
HMCUK
HYE
KQ8
OK1
PQQKQ
PROAC
QD8
RPM
UKHRP
Y2W
AAYXX
CITATION
AIKXB
EJD
IPNFZ
M48
NPM
RIG
SLJYH
3V.
7XB
8FK
K9.
PQEST
PQUKI
7X8
5PM
ID FETCH-LOGICAL-c533t-a47531aec5d41de4e3c1ab9a68e9a0077a01022df2b622bcc4505ec9b4d83d533
IEDL.DBID DOA
ISSN 2391-5463
IngestDate Wed Aug 27 01:28:39 EDT 2025
Thu Aug 21 18:33:42 EDT 2025
Mon Jul 21 11:33:25 EDT 2025
Sat Jul 26 02:24:33 EDT 2025
Mon Jul 21 05:47:30 EDT 2025
Tue Jul 01 01:31:59 EDT 2025
Thu Apr 24 23:11:54 EDT 2025
Thu Jul 10 10:37:46 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords COVID-19
predictive
progression
SARS-CoV-2
Coronavirus
Language English
License This work is licensed under the Creative Commons Attribution 4.0 International License.
http://creativecommons.org/licenses/by/4.0
2020 Yi-Hong Zhou et al., published by De Gruyter.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c533t-a47531aec5d41de4e3c1ab9a68e9a0077a01022df2b622bcc4505ec9b4d83d533
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
OpenAccessLink https://doaj.org/article/916ec700b8394889b7b29c2ca6453c03
PMID 33336038
PQID 2440232532
PQPubID 2040138
PageCount 10
ParticipantIDs doaj_primary_oai_doaj_org_article_916ec700b8394889b7b29c2ca6453c03
pubmedcentral_primary_oai_pubmedcentral_nih_gov_7712375
proquest_miscellaneous_2471466162
proquest_journals_2440232532
pubmed_primary_33336038
crossref_primary_10_1515_med_2020_0184
crossref_citationtrail_10_1515_med_2020_0184
walterdegruyter_journals_10_1515_med_2020_0184151805
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2020-01-01
PublicationDateYYYYMMDD 2020-01-01
PublicationDate_xml – month: 01
  year: 2020
  text: 2020-01-01
  day: 01
PublicationDecade 2020
PublicationPlace Poland
PublicationPlace_xml – name: Poland
– name: Warsaw
PublicationTitle Open medicine (Warsaw, Poland)
PublicationTitleAlternate Open Med (Wars)
PublicationYear 2020
Publisher De Gruyter
Walter de Gruyter GmbH
Publisher_xml – name: De Gruyter
– name: Walter de Gruyter GmbH
References Ahmed, AE (j_med-2020-0184_ref_013) 2017; 17
Yuan, J; Zou, R; Zeng, L; Kou, S; Lan, J; Li, X (j_med-2020-0184_ref_022) 2020; 69
Guo, W; Li, M; Dong, Y; Zhou, H; Zhang, Z; Tian, C (j_med-2020-0184_ref_012) 2020
Singhania, N; Bansal, S; Singhania, G (j_med-2020-0184_ref_007) 2020; 133
Huang, C; Wang, Y; Li, X; Ren, L; Zhao, J; Hu, Y (j_med-2020-0184_ref_003) 2020; 395
Alqahtani, FY; Aleanizy, FS; Ali El Hadi Mohamed, R; Alanazi, MS; Mohamed, N; Alrasheed, MM (j_med-2020-0184_ref_010) 2019; 147
Lee, N; Hui, D; Wu, A; Chan, P; Cameron, P; Joynt, GM (j_med-2020-0184_ref_019) 2003; 348
Alfaraj, SH; Al-Tawfiq, JA; Assiri, AY; Alzahrani, NA; Alanazi, AA; Memish, ZA (j_med-2020-0184_ref_014) 2019; 29
Wong, RS; Wu, A; To, KF; Lee, N; Lam, CW; Wong, CK (j_med-2020-0184_ref_023) 2003; 326
Gong, J; Ou, J; Qiu, X; Jie, Y; Chen, Y; Yuan, L (j_med-2020-0184_ref_016) 2020; 71
Lu, R; Zhao, X; Li, J; Niu, P; Yang, B; Wu, H (j_med-2020-0184_ref_001) 2020; 395
Oxley, TJ; Mocco, J; Majidi, S; Kellner, CP; Shoirah, H; Singh, IP (j_med-2020-0184_ref_008) 2020; 382
Al-Hameed, F; Wahla, AS; Siddiqui, S; Ghabashi, A; Al-Shomrani, M; Al-Thaqafi, A (j_med-2020-0184_ref_020) 2016; 31
Han, H; Xie, L; Liu, R; Yang, J; Liu, F; Wu, K (j_med-2020-0184_ref_018) 2020; 92
Leung, TW; Wong, KS; Hui, AC; To, KF; Lai, ST; Ng, WF (j_med-2020-0184_ref_021) 2005; 62
Chen, CY; Lee, CH; Liu, CY; Wang, JH; Wang, LM; Perng, RP (j_med-2020-0184_ref_015) 2005; 68
Wang, D; Hu, B; Hu, C; Zhu, F; Liu, X; Zhang, J (j_med-2020-0184_ref_009) 2020; 323
Chan, JF; Yuan, S; Kok, KH; To, KK; Chu, H; Yang, J (j_med-2020-0184_ref_004) 2020; 395
Assiri, A; Al-Tawfiq, JA; Al-Rabeeah, AA; Al-Rabiah, FA; Al-Hajjar, S; Al-Barrak, A (j_med-2020-0184_ref_011) 2013; 13
Chen, J; Qi, T; Liu, L; Ling, Y; Qian, Z; Li, T (j_med-2020-0184_ref_017) 2020; 80
Wong, SH; Lui, RN; Sung, JJ (j_med-2020-0184_ref_006) 2020; 35
Li, Q; Guan, X; Wu, P; Wang, X; Zhou, L; Tong, Y (j_med-2020-0184_ref_002) 2020; 382
Wang, C; Horby, PW; Hayden, FG; Gao, GF (j_med-2020-0184_ref_005) 2020; 395
2022052423224779272_j_med-2020-0184_ref_014_w2aab3b7d625b1b6b1ab2b2c14Aa
2022052423224779272_j_med-2020-0184_ref_019_w2aab3b7d625b1b6b1ab2b2c19Aa
2022052423224779272_j_med-2020-0184_ref_005_w2aab3b7d625b1b6b1ab2b2b5Aa
2022052423224779272_j_med-2020-0184_ref_007_w2aab3b7d625b1b6b1ab2b2b7Aa
2022052423224779272_j_med-2020-0184_ref_021_w2aab3b7d625b1b6b1ab2b2c21Aa
2022052423224779272_j_med-2020-0184_ref_017_w2aab3b7d625b1b6b1ab2b2c17Aa
2022052423224779272_j_med-2020-0184_ref_009_w2aab3b7d625b1b6b1ab2b2b9Aa
2022052423224779272_j_med-2020-0184_ref_020_w2aab3b7d625b1b6b1ab2b2c20Aa
2022052423224779272_j_med-2020-0184_ref_011_w2aab3b7d625b1b6b1ab2b2c11Aa
2022052423224779272_j_med-2020-0184_ref_016_w2aab3b7d625b1b6b1ab2b2c16Aa
2022052423224779272_j_med-2020-0184_ref_002_w2aab3b7d625b1b6b1ab2b2b2Aa
2022052423224779272_j_med-2020-0184_ref_023_w2aab3b7d625b1b6b1ab2b2c23Aa
2022052423224779272_j_med-2020-0184_ref_022_w2aab3b7d625b1b6b1ab2b2c22Aa
2022052423224779272_j_med-2020-0184_ref_004_w2aab3b7d625b1b6b1ab2b2b4Aa
2022052423224779272_j_med-2020-0184_ref_013_w2aab3b7d625b1b6b1ab2b2c13Aa
2022052423224779272_j_med-2020-0184_ref_018_w2aab3b7d625b1b6b1ab2b2c18Aa
2022052423224779272_j_med-2020-0184_ref_006_w2aab3b7d625b1b6b1ab2b2b6Aa
2022052423224779272_j_med-2020-0184_ref_012_w2aab3b7d625b1b6b1ab2b2c12Aa
2022052423224779272_j_med-2020-0184_ref_008_w2aab3b7d625b1b6b1ab2b2b8Aa
2022052423224779272_j_med-2020-0184_ref_003_w2aab3b7d625b1b6b1ab2b2b3Aa
2022052423224779272_j_med-2020-0184_ref_001_w2aab3b7d625b1b6b1ab2b2b1Aa
2022052423224779272_j_med-2020-0184_ref_010_w2aab3b7d625b1b6b1ab2b2c10Aa
2022052423224779272_j_med-2020-0184_ref_015_w2aab3b7d625b1b6b1ab2b2c15Aa
References_xml – volume: 13
  start-page: 752
  issue: 9
  year: 2013
  end-page: 61
  ident: j_med-2020-0184_ref_011
  article-title: Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study
  publication-title: Lancet Infect Dis
– volume: 395
  start-page: 470
  issue: 10223
  year: 2020
  end-page: 3
  ident: j_med-2020-0184_ref_005
  article-title: A novel coronavirus outbreak of global health concern
  publication-title: Lancet
– volume: 92
  start-page: 819
  issue: 7
  year: 2020
  end-page: 23
  ident: j_med-2020-0184_ref_018
  article-title: Analysis of heart injury laboratory parameters in 273 COVID-19 patients in one hospital in Wuhan, China
  publication-title: J Med Virol
  doi: 10.1002/jmv.25809
– volume: 147
  start-page: e35
  year: 2019
  ident: j_med-2020-0184_ref_010
  article-title: Prevalence of comorbidities in cases of Middle East respiratory syndrome coronavirus: a retrospective study
  publication-title: Epidemiol Infect
  doi: 10.1017/S0950268818002923
– volume: 69
  start-page: 599
  issue: 6
  year: 2020
  end-page: 606
  ident: j_med-2020-0184_ref_022
  article-title: The correlation between viral clearance and biochemical outcomes of 94 COVID-19 infected discharged patients
  publication-title: Inflamm Res
– volume: 17
  start-page: 615
  issue: 1
  year: 2017
  ident: j_med-2020-0184_ref_013
  article-title: The predictors of 3- and 30-day mortality in 660 MERS-CoV patients
  publication-title: BMC Infect Dis
– volume: 382
  start-page: e60
  issue: 20
  year: 2020
  ident: j_med-2020-0184_ref_008
  article-title: Large-vessel stroke as a presenting feature of Covid-19 in the young
  publication-title: N Engl J Med
– volume: 35
  start-page: 744
  issue: 5
  year: 2020
  end-page: 8
  ident: j_med-2020-0184_ref_006
  article-title: Covid-19 and the digestive system
  publication-title: J Gastroenterol Hepatol
– volume: 133
  start-page: e365
  issue: 7
  year: 2020
  end-page: 6
  ident: j_med-2020-0184_ref_007
  article-title: An atypical presentation of novel coronavirus disease 2019 (COVID-19)
  publication-title: Am J Med
  doi: 10.1016/j.amjmed.2020.03.026
– volume: 326
  start-page: 1358
  issue: 7403
  year: 2003
  end-page: 62
  ident: j_med-2020-0184_ref_023
  article-title: Haematological manifestations in patients with severe acute respiratory syndrome: retrospective analysis
  publication-title: BMJ
– volume: 395
  start-page: 565
  issue: 10224
  year: 2020
  end-page: 74
  ident: j_med-2020-0184_ref_001
  article-title: Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding
  publication-title: Lancet
– volume: 382
  start-page: 1199
  issue: 13
  year: 2020
  end-page: 207
  ident: j_med-2020-0184_ref_002
  article-title: Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia
  publication-title: N Engl J Med
– volume: 31
  start-page: 344
  issue: 5
  year: 2016
  end-page: 8
  ident: j_med-2020-0184_ref_020
  article-title: Characteristics and outcomes of middle east respiratory syndrome coronavirus patients admitted to an intensive care unit in Jeddah, Saudi Arabia
  publication-title: J Intensive Care Med
– volume: 62
  start-page: 1113
  issue: 7
  year: 2005
  end-page: 7
  ident: j_med-2020-0184_ref_021
  article-title: Myopathic changes associated with severe acute respiratory syndrome: a postmortem case series
  publication-title: Arch Neurol
– volume: 29
  start-page: 48
  year: 2019
  end-page: 50
  ident: j_med-2020-0184_ref_014
  article-title: Clinical predictors of mortality of Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection: a cohort study
  publication-title: Travel Med Infect Dis
– volume: 395
  start-page: 514
  issue: 10223
  year: 2020
  end-page: 23
  ident: j_med-2020-0184_ref_004
  article-title: A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster
  publication-title: Lancet
– volume: 68
  start-page: 4
  issue: 1
  year: 2005
  end-page: 10
  ident: j_med-2020-0184_ref_015
  article-title: Clinical features and outcomes of severe acute respiratory syndrome and predictive factors for acute respiratory distress syndrome
  publication-title: J Chin Med Assoc
– volume: 71
  start-page: 833
  issue: 15
  year: 2020
  end-page: 40
  ident: j_med-2020-0184_ref_016
  article-title: A tool to early predict severe corona virus disease 2019 (COVID-19): a multicenter study using the risk nomogram in Wuhan and Guangdong, China
  publication-title: Clin Infect Dis
  doi: 10.1093/cid/ciaa443
– start-page: e3319
  year: 2020
  ident: j_med-2020-0184_ref_012
  article-title: Diabetes is a risk factor for the progression and prognosis of COVID-19
  publication-title: Diabetes Metab Res Rev
  doi: 10.1002/dmrr.3319
– volume: 323
  start-page: 1061
  issue: 11
  year: 2020
  end-page: 9
  ident: j_med-2020-0184_ref_009
  article-title: Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China
  publication-title: JAMA
  doi: 10.1001/jama.2020.1585
– volume: 80
  start-page: e1
  issue: 5
  year: 2020
  end-page: e6
  ident: j_med-2020-0184_ref_017
  article-title: Clinical progression of patients with COVID-19 in Shanghai, China
  publication-title: J Infect
– volume: 348
  start-page: 1986
  issue: 20
  year: 2003
  end-page: 94
  ident: j_med-2020-0184_ref_019
  article-title: A major outbreak of severe acute respiratory syndrome in Hong Kong
  publication-title: N Engl J Med
– volume: 395
  start-page: 497
  issue: 10223
  year: 2020
  end-page: 506
  ident: j_med-2020-0184_ref_003
  article-title: Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
  publication-title: Lancet
– ident: 2022052423224779272_j_med-2020-0184_ref_020_w2aab3b7d625b1b6b1ab2b2c20Aa
  doi: 10.1177/0885066615579858
– ident: 2022052423224779272_j_med-2020-0184_ref_022_w2aab3b7d625b1b6b1ab2b2c22Aa
  doi: 10.1007/s00011-020-01342-0
– ident: 2022052423224779272_j_med-2020-0184_ref_023_w2aab3b7d625b1b6b1ab2b2c23Aa
  doi: 10.1136/bmj.326.7403.1358
– ident: 2022052423224779272_j_med-2020-0184_ref_010_w2aab3b7d625b1b6b1ab2b2c10Aa
  doi: 10.1017/S0950268818002923
– ident: 2022052423224779272_j_med-2020-0184_ref_016_w2aab3b7d625b1b6b1ab2b2c16Aa
  doi: 10.1093/cid/ciaa443
– ident: 2022052423224779272_j_med-2020-0184_ref_018_w2aab3b7d625b1b6b1ab2b2c18Aa
  doi: 10.1002/jmv.25809
– ident: 2022052423224779272_j_med-2020-0184_ref_009_w2aab3b7d625b1b6b1ab2b2b9Aa
  doi: 10.1001/jama.2020.1585
– ident: 2022052423224779272_j_med-2020-0184_ref_021_w2aab3b7d625b1b6b1ab2b2c21Aa
  doi: 10.1001/archneur.62.7.1113
– ident: 2022052423224779272_j_med-2020-0184_ref_012_w2aab3b7d625b1b6b1ab2b2c12Aa
  doi: 10.1002/dmrr.3319
– ident: 2022052423224779272_j_med-2020-0184_ref_007_w2aab3b7d625b1b6b1ab2b2b7Aa
  doi: 10.1016/j.amjmed.2020.03.026
– ident: 2022052423224779272_j_med-2020-0184_ref_019_w2aab3b7d625b1b6b1ab2b2c19Aa
  doi: 10.1056/NEJMoa030685
– ident: 2022052423224779272_j_med-2020-0184_ref_004_w2aab3b7d625b1b6b1ab2b2b4Aa
  doi: 10.1016/S0140-6736(20)30154-9
– ident: 2022052423224779272_j_med-2020-0184_ref_006_w2aab3b7d625b1b6b1ab2b2b6Aa
  doi: 10.1111/jgh.15047
– ident: 2022052423224779272_j_med-2020-0184_ref_015_w2aab3b7d625b1b6b1ab2b2c15Aa
  doi: 10.1016/S1726-4901(09)70124-8
– ident: 2022052423224779272_j_med-2020-0184_ref_002_w2aab3b7d625b1b6b1ab2b2b2Aa
  doi: 10.1056/NEJMoa2001316
– ident: 2022052423224779272_j_med-2020-0184_ref_011_w2aab3b7d625b1b6b1ab2b2c11Aa
  doi: 10.1016/S1473-3099(13)70204-4
– ident: 2022052423224779272_j_med-2020-0184_ref_013_w2aab3b7d625b1b6b1ab2b2c13Aa
  doi: 10.1186/s12879-017-2712-2
– ident: 2022052423224779272_j_med-2020-0184_ref_005_w2aab3b7d625b1b6b1ab2b2b5Aa
  doi: 10.1016/S0140-6736(20)30185-9
– ident: 2022052423224779272_j_med-2020-0184_ref_008_w2aab3b7d625b1b6b1ab2b2b8Aa
  doi: 10.1056/NEJMc2009787
– ident: 2022052423224779272_j_med-2020-0184_ref_017_w2aab3b7d625b1b6b1ab2b2c17Aa
  doi: 10.1016/j.jinf.2020.03.004
– ident: 2022052423224779272_j_med-2020-0184_ref_003_w2aab3b7d625b1b6b1ab2b2b3Aa
  doi: 10.1016/S0140-6736(20)30183-5
– ident: 2022052423224779272_j_med-2020-0184_ref_014_w2aab3b7d625b1b6b1ab2b2c14Aa
  doi: 10.1016/j.tmaid.2019.03.004
– ident: 2022052423224779272_j_med-2020-0184_ref_001_w2aab3b7d625b1b6b1ab2b2b1Aa
  doi: 10.1016/S0140-6736(20)30251-8
SSID ssj0001537970
Score 2.14376
Snippet Early diagnosis and treatment are crucial for the survival of severe Coronavirus Disease 2019 (COVID-19) patients, but data with regard to risk factors for...
SourceID doaj
pubmedcentral
proquest
pubmed
crossref
walterdegruyter
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 805
SubjectTerms Coronavirus
Coronaviruses
COVID-19
Hospitalization
Hospitals
Infectious diseases
Laboratories
Medical diagnosis
Medical prognosis
Patients
predictive
progression
Public health
Risk factors
SARS-CoV-2
Sepsis
Severe acute respiratory syndrome coronavirus 2
SummonAdditionalLinks – databaseName: ProQuest Health & Medical Collection
  dbid: 7X7
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3di9QwEB_0BBHk0POrekoF8clwTZMmzZPo6XEKpz54sm8hXz0Fac9eF_G_d5Jmd1k9XfapGZZ0ZpLfJDP7G4BnrVSdcdKQzilOEK8ZMa6lhFnWUe_QqRJ358kHcXzK3y-aRb5wu8hllas9MW3UfnDxjvwAYQjhpW5Y_fL8B4ldo2J2NbfQuArXInVZLOmSC7m5Y2mYVLLK1JqI3AeIMOgXdazFavkWFCXG_svCzL-rJXd_pky2D2fj8te0ypwmQDq6Bbs5kixfzaa_DVdCvwfXT3KufA9uzjdy5fxHozvAP41xLG5vZe6yUw5dmQq0ZnKOchpKBMowhvLw45d3bwhVd-H06O3nw2OSeyYQh4HbRAzH8wc1wTWeUx94YI4aq4xogzKRu8ckEjnf1VbUtXWOYwgUnLLct8zjT9yDnX7owwMoJQ-eWhnwTBbiQcta6oWStmlF26EpC3ixUp92mVA89rX4ruPBArWtUWk6altHbRfwfC1-PjNp_EvwdbTFWigSYKcHw3im83rSGNUGJ6vKYoCHe5Cy0tbK1c4I3jBXsQL2V5bUeVVe6I0PFfB0PYzrKSZJTB-GZZSRCB6CCpS5Pxt-PROGH1GxtgC55RJbU90e6b99TZzdUmKIIJsC-B_Os5ndpcrAJ23VPPz_2zyCG9mp8bsPO9O4DI8xVprsk7QgfgMqjhFR
  priority: 102
  providerName: ProQuest
Title Predictive factors of progression to severe COVID-19
URI https://www.degruyter.com/doi/10.1515/med-2020-0184
https://www.ncbi.nlm.nih.gov/pubmed/33336038
https://www.proquest.com/docview/2440232532
https://www.proquest.com/docview/2471466162
https://pubmed.ncbi.nlm.nih.gov/PMC7712375
https://doaj.org/article/916ec700b8394889b7b29c2ca6453c03
Volume 15
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1daxQxFL1oBfGl-O3YuowgPjl0Msnk49HWlqq0VrGybyFfUwWZlXUW6b_3JpPddmvFF4dlWDKXIZyc7D2XZE8AXkihOuOEqTqnWIX5mlbGSVJRSzviHZIqeXceHfPDU_Zu2k4vHfUV94SN9sAjcDsoX4ITdW0xkyPZlBW2Ua5xhrOWutHnE3PepWJq_H8wFUrU2VQTc_YO5hZkRBN3YUm2loSSV_91AvPPfZKbv9Iatg9n88X5sFwzTano4C5sZg1Zvh77fg9uhP4-3D7Kq-QPgJ3M4_f4Q1bm83TKWVemrVijDUc5zEpMiWEeyr0PX96-qYh6CKcH-5_3Dqt8OkLlUKINlWFYaRATXOsZ8YEF6oixynAZlIkuPSbZxfmusbxprHMMxU5wyjIvqcdXPIKNftaHJ1AKFjyxImD1FWJJZS3xXAnbSi47HLQCXi3h0i5bh8cTLL7rWEIguhpB0hFdHdEt4OUq_MfomfG3wN2I_SooWl2nBiSAzgTQ_yJAAdvLkdN5_v3UKFpQjDQtbQp4vnqMMycuh5g-zBYxRmCa4IRjzONxoFc9oXjxmsoCxBoF1rq6_qT_9jW5cwuBYkC0BbArZLno3bVgYIus26f_A5ItuJOpjp9t2Bjmi_AMtdNgJ3BTTMUEbu3uH598mqRJg_f3H-VvmBQXcw
linkProvider Directory of Open Access Journals
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwEB5VWwmQUAXlFSgQJOBE1MR24viAEH1pl3aXCrWoN9d2nIKEkrLNquqf4jcyTpxdLRRuXeUUz8E7Hs9843G-AXidc1Eqw1VUGsEijNc0UiZPIqppmRQGjarl7hxPsuEx-3SSnqzAr_5bGHetsveJraMuauPOyDcxDGF4ISklH85_Rq5rlKuu9i00OrPYt1eXmLJdvB_t4Pq-IWRv92h7GPmuApFBaNNEiiFCT5Q1acGSwjJLTaK0UFluhXLsNqqlWStKojNCtDEMQYI1QrMip0XqDkDR5a8yiqnMAFa3dieHXxanOinlgseezBOxwibGNLRE4m5_5Wwp-LU9Aq4Dtn_fz1y7bGvnhT2bzq6avlbbhsC9e7DmsWv4sTO2-7Biq3W4NfbV-XW4250Bht2nTQ-AHU7dmHOooe_rE9Zl2F4J6-hAwqYOMTTbqQ23P38d7USJeAjHN6LPRzCo6so-gZAzWySaW8wCrUvttE6KTHCd5lleovEE8K5XnzSewtx10vghXSqD2paoNOm0LZ22A3g7Fz_vuDv-Jbjl1mIu5Ci32xf19Ez6HSwRR1vD41gjpESvJzTXRBhiVMZSamIawEa_ktL7gQu5sNoAXs2HcQe7soyqbD1zMhzDVZZkKPO4W_j5TCj-spjmAfAlk1ia6vJI9f1byxLOOYISngbA_jCexeyuVQa-yeP06f__zUu4PTwaH8iD0WT_GdzxBo7PBgya6cw-R6TW6Bd-e4RwetM78jfINE_Q
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB7BVqq4VJRXUwoECXEi2iR27PhY2i5boA8Jinqz_EpBqpIqZIX67ztO3LRLy4Uoh8ieRNbM2PON7XwGeFdyUSnDVVIZQROM1yRRpswSokmVWYNO1XN3Hhyy-Qn9fFqc3vqL32-rtO6sXVx2A0Pq1DZm4SfKRq4BjMBTjBRo39zvqSrp9MJWD2GFMUHoBFa255--Hd3MsxSEC54Ges077y6Fo561_z6oeXfH5NqffjV7bOqtoDR7DGsBTcbbg_nX4YGrn8DqQVgvfwr0uPXPfkiLw8k6cVPF_aasgZAj7poYg6NrXbxz9GN_N8nEMziZ7X3fmSfhnITEIFjrEkUx58iUM4WlmXXUEZMpLRQrnVCer0f1xHG2yjXLc20MRdjjjNDUlsTiJ57DpG5qtwExp85mmjvMw5xPrrTOLBNcFyUrKzRfBB-u1SVNIBH3Z1mcS59MoHYlKkl67Uqv3Qjej-IXA3vGvwQ_et2PQp70ui9o2jMZ-pBEJOsMT1ONoA7HHaG5zoXJjWK0ICYlEWxdW06GnvhbInxBWJIXJI_g7ViNfcgvjKjaNQsvwzFgsIyhzIvB0GNLCF4sJWUEfMkFlpq6XFP_-tnzdHOOsIAXEdC_nOWmdfcqA0vKtNj8v9fewOrx7kx-3T_88hIeBT_HewsmXbtwrxBCdfp16CVXIygWrw
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Predictive+factors+of+progression+to+severe+COVID-19&rft.jtitle=Open+medicine+%28Warsaw%2C+Poland%29&rft.au=Zhou%2C+Yi-Hong&rft.au=Li%2C+Huan&rft.au=Qin%2C+Yuan-Yuan&rft.au=Yan%2C+Xiao-Feng&rft.date=2020-01-01&rft.pub=De+Gruyter&rft.eissn=2391-5463&rft.volume=15&rft.issue=1&rft.spage=805&rft.epage=814&rft_id=info:doi/10.1515%2Fmed-2020-0184&rft.externalDBID=n%2Fa&rft.externalDocID=10_1515_med_2020_0184151805
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2391-5463&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2391-5463&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2391-5463&client=summon